These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31649363)

  • 1. The Role of High Mobility Group Box-1 in Epileptogenesis.
    Fu L; Nishibori M
    Acta Med Okayama; 2019 Oct; 73(5):383-386. PubMed ID: 31649363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Immunosuppressive Function of Myeloid-derived Suppressor Cells Is Regulated by the HMGB1-TLR4 Axis].
    Tachibana M
    Yakugaku Zasshi; 2018; 138(2):143-148. PubMed ID: 29386427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.
    Ravizza T; Terrone G; Salamone A; Frigerio F; Balosso S; Antoine DJ; Vezzani A
    Brain Behav Immun; 2018 Aug; 72():14-21. PubMed ID: 29031614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of high mobility group box 1 (HMGB1) in cultured human periodontal ligament cells].
    Hasegawa N
    Kokubyo Gakkai Zasshi; 2008 Oct; 75(3):155-61. PubMed ID: 19044016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HMGB1 in inflammation-mediated organ injury.
    Asavarut P; Zhao H; Gu J; Ma D
    Acta Anaesthesiol Taiwan; 2013 Mar; 51(1):28-33. PubMed ID: 23711603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the high mobility group box 1 signalling axes via the receptor for advanced glycation end-products and toll-like receptor-4 in the immunopathology of oral lichen planus: a potential drug target?
    Salem A; Almahmoudi R; Vehviläinen M; Salo T
    Eur J Oral Sci; 2018 Jun; 126(3):244-248. PubMed ID: 29676511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke.
    Hayakawa K; Qiu J; Lo EH
    Ann N Y Acad Sci; 2010 Oct; 1207():50-7. PubMed ID: 20955426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Mobility Group Box-1 and Blood-Brain Barrier Disruption.
    Nishibori M; Wang D; Ousaka D; Wake H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
    Leung SS; Forbes JM; Borg DJ
    Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures.
    Nass RD; Wagner M; Surges R; Holdenrieder S
    Epilepsy Res; 2020 May; 162():106301. PubMed ID: 32126476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression.
    Angelopoulou E; Piperi C; Adamopoulos C; Papavassiliou AG
    J Mol Med (Berl); 2016 Aug; 94(8):867-74. PubMed ID: 27262996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility group box-1 in sterile inflammation.
    Tsung A; Tohme S; Billiar TR
    J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
    Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
    Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1-RAGE signaling pathway in pPROM.
    Yan H; Zhu L; Zhang Z; Li H; Li P; Wang Y; Leng M
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):211-216. PubMed ID: 29673663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
    Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
    AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage.
    Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B
    Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1 as a DNA-binding cytokine.
    Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
    J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HMGB1 in cardiovascular diseases.
    Li W; Sama AE; Wang H
    Curr Opin Pharmacol; 2006 Apr; 6(2):130-5. PubMed ID: 16487750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
    Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Nomoto M; Miyashita S; Suzuki K; Nakamura M; Watanabe K
    Exp Dermatol; 2015 Jun; 24(6):418-23. PubMed ID: 25739980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.